Skip to main content

Articles

103 result(s) for 'copd di' within Respiratory Research

Page 1 of 3

  1. It has been suggested that withdrawal of inhaled corticosteroids (ICS) in COPD patients on maintenance treatment results in deterioration of symptoms, lung function and exacerbations. The aim of this real-life...

    Authors: Andrea Rossi, Massimo Guerriero and Antonio Corrado
    Citation: Respiratory Research 2014 15:77
  2. In the original publication [1] is an incorrect sentence in the abstract under Conclusions.

    Authors: Fabiano Di Marco, Giovanni Sotgiu, Pierachille Santus, Denis E. O’Donnell, Kai-Michael Beeh, Simone Dore, Maria Adelaide Roggi, Lisa Giuliani, Francesco Blasi and Stefano Centanni
    Citation: Respiratory Research 2018 19:70

    The original article was published in Respiratory Research 2018 19:18

  3. To study the regulatory effect of Long non-coding RNA (LncRNA) HOX transcript antisense RNA (HOTAIR) on pulmonary vascular endothelial cell (HPVEC) apoptosis and determine whether the HOTAIR facilitate HPVEC a...

    Authors: Zhongshang Dai, Xiangming Liu, Huihui Zeng and Yan Chen
    Citation: Respiratory Research 2022 23:356
  4. A persistent low inflammatory-oxidative status and the inadequacy of the antioxidant nuclear factor-E2-related factor 2 (Nrf2) have been implicated in chronic obstructive pulmonary disease (COPD) progression. ...

    Authors: A. M. Fratta Pasini, C. Stranieri, M. Ferrari, U. Garbin, L. Cazzoletti, C. Mozzini, F. Spelta, D. Peserico and L. Cominacini
    Citation: Respiratory Research 2020 21:37

    The Correction to this article has been published in Respiratory Research 2020 21:213

  5. Persistent airflow limitation and dyspnoea may reduce chronic obstructive pulmonary disease (COPD) patients exercise capacity and physical activity, undermining their physical status and quality of life. Long-...

    Authors: Marc Miravitlles, Juan Luís García-Rivero, Xavier Ribera, Jordi Galera, Alejandra García, Rosa Palomino and Xavier Pomares
    Citation: Respiratory Research 2022 23:347
  6. Emphysema is a crucial pathological characteristic of chronic obstructive pulmonary disease (COPD). Oxidative stress, apoptosis and epigenetic mechanisms contribute to the pathogenesis of emphysema. However, a...

    Authors: Huihui Zeng, Tiao Li, Xue He, Shan Cai, Hong Luo, Ping Chen and Yan Chen
    Citation: Respiratory Research 2020 21:229
  7. Alpha-1 antitrypsin is the main inhibitor of neutrophil elastase in the lung. Although it is principally synthesized by hepatocytes, alpha-1 antitrypsin is also secreted by bronchial epithelial cells. Gene mut...

    Authors: Laura Pini, Laura Tiberio, Narayanan Venkatesan, Michela Bezzi, Luciano Corda, Maurizio Luisetti, Ilaria Ferrarotti, Mario Malerba, David A Lomas, Sabina Janciauskiene, Enrico Vizzardi, Denise Modina, Luisa Schiaffonati and Claudio Tantucci
    Citation: Respiratory Research 2014 15:112
  8. Electronic cigarettes (ECs) are battery-operated devices designed to vaporise nicotine, which may help smokers quitting or reducing their tobacco consumption. There is a lack of data on the health effects of E...

    Authors: Riccardo Polosa, Jaymin Bhagwanji Morjaria, Pasquale Caponnetto, Umberto Prosperini, Cristina Russo, Alfio Pennisi and Cosimo Marcello Bruno
    Citation: Respiratory Research 2016 17:166
  9. The meeting proved of great interest to those developing an animal model of chronic obstructive pulmonary disease (COPD). COPD is caused by cigarette smoking, evidenced by deterioration in lung function. Lung ...

    Authors: David Hele
    Citation: Respiratory Research 2001 3:12
  10. Tidal expiratory flow limitation (EFLT) promotes intrinsic PEEP (PEEPi) in patients with chronic obstructive pulmonary disease (COPD). Applying non-invasive ventilation (NIV) with an expiratory positive airway pr...

    Authors: Emanuela Zannin, Ilaria Milesi, Roberto Porta, Simona Cacciatore, Luca Barbano, R. Trentin, Francesco Fanfulla, Michele Vitacca and Raffaele L. Dellacà
    Citation: Respiratory Research 2020 21:301
  11. The long-term effect of average volume-assured pressure support (AVAPS) on health-related quality of life (HRQOL) in chronic obstructive pulmonary disease (COPD) patients with chronic hypercapnic respiratory f...

    Authors: Doaa M. Magdy and Ahmed Metwally
    Citation: Respiratory Research 2020 21:64
  12. No short patient-reported outcome (PRO) instruments assess overall health status across different obstructive lung diseases. Thus, the wording of the introduction to the Chronic Obstructive Pulmonary Disease (...

    Authors: Erin L. Tomaszewski, Mark J. Atkinson, Christer Janson, Niklas Karlsson, Barry Make, David Price, Helen K. Reddel, Claus F. Vogelmeier, Hana Müllerová and Paul W. Jones
    Citation: Respiratory Research 2023 24:106
  13. COPD is a common, highly debilitating disease of the airways, primarily caused by smoking. Chronic inflammation and structural remodelling are key pathological features of this disease caused, in part, by the ...

    Authors: Mark M. Perry, Bernadett Tildy, Alberto Papi, Paolo Casolari, Gaetano Caramori, Karen Limbert Rempel, Andrew J. Halayko, Ian Adcock and Kian Fan Chung
    Citation: Respiratory Research 2018 19:85

    The Retraction Note to this article has been published in Respiratory Research 2021 22:235

  14. Oxidative stress is recognized to be one of predisposing factor in the pathogenesis of COPD. The oxidant/antioxidant imbalance is significantly pronounced in patients with COPD exacerbation. N-acetylcysteine (...

    Authors: Mario Cazzola, Luigino Calzetta, Francesco Facciolo, Paola Rogliani and Maria Gabriella Matera
    Citation: Respiratory Research 2017 18:26
  15. Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death worldwide. Identifying COPD-associated DNA methylation marks in African-Americans may contribute to our understanding of racial ...

    Authors: Robert Busch, Weiliang Qiu, Jessica Lasky-Su, Jarrett Morrow, Gerard Criner and Dawn DeMeo
    Citation: Respiratory Research 2016 17:143
  16. We carried out a systematic review and meta-analysis with the aim to evaluate the efficacy of long-acting bronchodilators on exercise capacity in COPD patients.

    Authors: Fabiano Di Marco, Giovanni Sotgiu, Pierachille Santus, Denis E. O’Donnell, Kai-Michael Beeh, Simone Dore, Maria Adelaide Roggi, Lisa Giuliani, Francesco Blasi and Stefano Centanni
    Citation: Respiratory Research 2018 19:18

    The Correction to this article has been published in Respiratory Research 2018 19:70

  17. Patients with chronic obstructive pulmonary disease (COPD) have high oxidative stress associated with the severity of the disease. Nuclear factor erythroid-2 related factor 2 (Nrf2)-directed stress response pl...

    Authors: Venkataramana K. Sidhaye, Janet T. Holbrook, Alyce Burke, Kuladeep R. Sudini, Sanjay Sethi, Gerard J. Criner, Jed W. Fahey, Charles S. Berenson, Michael R. Jacobs, Rajesh Thimmulappa, Robert A. Wise and Shyam Biswal
    Citation: Respiratory Research 2019 20:190
  18. Macrophages constitute a heterogeneous cell population with pro- (MΦ1) and anti-inflammatory (MΦ2) cells. The soluble chitinase-like-protein YKL-40 is expressed in macrophages and various other cell types, and...

    Authors: L. I. Z. Kunz, E. F. A. van’t Wout, A. van Schadewijk, D. S. Postma, H. A. M. Kerstjens, P. J. Sterk and P. S. Hiemstra
    Citation: Respiratory Research 2015 16:154
  19. As emphasized by international recommendations and largely confirmed by clinical experience, long-acting bronchodilators play a central role in the maintenance treatment of chronic obstructive pulmonary diseas...

    Authors: F. Blasi, G. W. Canonica and M. Miravitlles
    Citation: Respiratory Research 2017 18:19

    The Erratum to this article has been published in Respiratory Research 2017 18:35

  20. Functional deficiency of mannose-binding lectin (MBL) may contribute to the pathogenesis of chronic obstructive pulmonary disease. We hypothesized that specific MBL2 gene polymorphisms and circulating MBL prot...

    Authors: Jyotshna Mandal, Bijaya Malla, Rudi Steffensen, Luigi Costa, Adrian Egli, Marten Trendelenburg, Francesco Blasi, Kostantinos Kostikas, Tobias Welte, Antoni Torres, Renaud Louis, Wim Boersma, Branislava Milenkovic, Joachim Aerts, Gernot G. U. Rohde, Alicia Lacoma…
    Citation: Respiratory Research 2015 16:150
  21. This study forms part of the first complete characterization of the dose–response curve for glycopyrrolate (GP) delivered using Co-Suspension™ Delivery Technology via a metered dose inhaler (MDI). We examined ...

    Authors: Leonardo M. Fabbri, Edward M. Kerwin, Selwyn Spangenthal, Gary T. Ferguson, Roberto Rodriguez-Roisin, James Pearle, Sanjay Sethi, Chad Orevillo, Patrick Darken, Earl St. Rose, Tracy Fischer, Michael Golden, Sarvajna Dwivedi and Colin Reisner
    Citation: Respiratory Research 2016 17:109
  22. Chronic obstructive pulmonary disease (COPD) is a major global health problem and is predicted to become the third most common cause of death by 2020. Apart from the important preventive steps of smoking cessa...

    Authors: David A Groneberg and K Fan Chung
    Citation: Respiratory Research 2004 5:18
  23. Chronic obstructive pulmonary disease (COPD) is a progressive disorder that causes airway obstruction and lung inflammation. The first-line treatment of COPD is the bronchodilators of β2-agonists and antimusca...

    Authors: Di Liu, Wen Xu, Yuan Tang, Jingxue Cao, Ran Chen, Dingwei Wu, Hongpeng Chen, Bo Su and Jinfu Xu
    Citation: Respiratory Research 2022 23:380
  24. Chronic obstructive pulmonary disease (COPD) is a progressive and irreversible chronic inflammatory disease of the lung. The nature of the immune reaction in COPD raises the possibility that IL-17 and related ...

    Authors: Ying Chang, Jessica Nadigel, Nicholas Boulais, Jean Bourbeau, François Maltais, David H Eidelman and Qutayba Hamid
    Citation: Respiratory Research 2011 12:43
  25. Chronic obstructive pulmonary disease (COPD) is projected to become the third cause of mortality worldwide. COPD shares several pathophysiological mechanisms with cardiovascular disease, especially atheroscler...

    Authors: Giuseppe De Luca, Matteo Nardin, Magdy Algowhary, Berat Uguz, Dinaldo C. Oliveira, Vladimir Ganyukov, Zan Zimbakov, Miha Cercek, Lisette Okkels Jensen, Poay Huan Loh, Lucian Calmac, Gerard Roura Ferrer, Alexandre Quadros, Marek Milewski, Fortunato Scotto di Uccio, Clemens von Birgelen…
    Citation: Respiratory Research 2022 23:207
  26. There is an increasing interest in the potential of exhaled biomarkers, such as volatile organic compounds (VOCs), to improve accurate diagnoses and management decisions in pulmonary diseases. The objective of...

    Authors: Kim DG van de Kant, Linda JTM van der Sande, Quirijn Jöbsis, Onno CP van Schayck and Edward Dompeling
    Citation: Respiratory Research 2012 13:117
  27. In asthma, higher chymase positive mast cell (MC-C) numbers are associated with less airway obstruction. In COPD, the distribution of MC-C and tryptase positive mast cells (MC-T) in central and peripheral airw...

    Authors: Margot ME Gosman, Dirkje S Postma, Judith M Vonk, Bea Rutgers, Monique Lodewijk, Mieke Smith, Marjan A Luinge, Nick HT ten Hacken and Wim Timens
    Citation: Respiratory Research 2008 9:64
  28. Little is known about the relationships between human genetics and the airway microbiome. Deeply sequenced airway metagenomics, by simultaneously characterizing the microbiome and host genetics, provide a uniq...

    Authors: Jingyuan Gao, Yuqiong Yang, Xiaopeng Xiang, Huimin Zheng, Xinzhu Yi, Fengyan Wang, Zhenyu Liang, Dandan Chen, Weijuan Shi, Lingwei Wang, Di Wu, Shengchuan Feng, Qiaoyun Huang, Xueping Li, Wensheng Shu, Rongchang Chen…
    Citation: Respiratory Research 2024 25:165
  29. Patients with chronic obstructive pulmonary disease (COPD) have a modified clinical presentation of venous thromboembolism (VTE) but also a worse prognosis than non-COPD patients with VTE. As it may induce the...

    Authors: Laurent Bertoletti, Sara Quenet, Silvy Laporte, Joan Carles Sahuquillo, Francisco Conget, José María Pedrajas, Mar Martin, Ignacio Casado, Antonio Riera-Mestre and Manuel Monreal
    Citation: Respiratory Research 2013 14:75
  30. Identification of COPD patients with a rapid decline in FEV1 is of particular interest for prognostic and therapeutic reasons.

    Authors: Antonino Di Stefano, Francesca Dossena, Isabella Gnemmi, Silvestro Ennio D’Anna, Paola Brun, Bruno Balbi, Alessio Piraino, Antonio Spanevello, Francesco Nucera, Vitina Carriero, Francesca Bertolini, Mauro Maniscalco, Ian M. Adcock, Gaetano Caramori and Fabio L. M. Ricciardolo
    Citation: Respiratory Research 2022 23:200
  31. Chronic obstructive pulmonary disease (COPD) is associated with local and systemic inflammation. The knowledge of interaction and co-variation of the inflammatory responses in different compartments is meagre.

    Authors: Jie Ji, Ida von Schéele, Jan Bergström, Bo Billing, Barbro Dahlén, Ann-Sofie Lantz, Kjell Larsson and Lena Palmberg
    Citation: Respiratory Research 2014 15:104
  32. Chronic obstructive pulmonary disease is associated with a chronic inflammatory response of the host to chronic exposure to inhaled toxic gases and particles. Although inflammatory cells of both the innate and...

    Authors: An I D'hulst, Tania Maes, Ken R Bracke, Ingel K Demedts, Kurt G Tournoy, Guy F Joos and Guy G Brusselle
    Citation: Respiratory Research 2005 6:147
  33. Retinoid X receptors (RXRs) are members of the nuclear receptor (NR) superfamily that mediate signalling by 9-cis retinoic acid, a vitamin A derivative. RXRs play key roles not only as homodimers but also as h...

    Authors: Daisuke Morichika, Nobuaki Miyahara, Utako Fujii, Akihiko Taniguchi, Naohiro Oda, Satoru Senoo, Mikio Kataoka, Mitsune Tanimoto, Hiroki Kakuta, Katsuyuki Kiura, Yoshinobu Maeda and Arihiko Kanehiro
    Citation: Respiratory Research 2019 20:2
  34. Chronic obstructive pulmonary disease (COPD) is a progressive condition characterized by airflow limitation associated with an abnormal inflammatory response of the lungs to noxious particles and gases, caused...

    Authors: Elisabetta Zinellu, Angelo Zinellu, Alessandro Giuseppe Fois, Ciriaco Carru and Pietro Pirina
    Citation: Respiratory Research 2016 17:150
  35. Nutritional immunity is the sequestration of bioavailable trace metals such as iron, zinc and copper by the host to limit pathogenicity by invading microorganisms. As one of the most conserved activities of th...

    Authors: Claire Healy, Natalia Munoz-Wolf, Janné Strydom, Lynne Faherty, Niamh C. Williams, Sarah Kenny, Seamas C. Donnelly and Suzanne M. Cloonan
    Citation: Respiratory Research 2021 22:133
  36. Chronic obstructive pulmonary disease (COPD) is a frequently encountered disease condition in clinical practice mainly caused by cigarette smoke (CS). The aim of this study was to investigate the protective ro...

    Authors: Zhixing Zhu, Xihua Lian, Xiaoshan Su, Weijing Wu, Yiming Zeng and Xiaoyang Chen
    Citation: Respiratory Research 2022 23:5
  37. Patients with chronic obstructive pulmonary disease (COPD) have a high incidence of cardiovascular disease including thromboembolisms. Fibrin degradation products, like D-dimer, have been associated with death...

    Authors: Peter Kamstrup, Pradeesh Sivapalan, Christian Rønn, Ema Rastoder, Daniel Modin, Anna Kjaer Kristensen, Elisabeth Bendstrup, Rikke Sørensen, Tor Biering-Sørensen, Charlotte Suppli Ulrik, Jørgen Vestbo and Jens-Ulrik Jensen
    Citation: Respiratory Research 2023 24:172
  38. Chronic obstructive pulmonary disease (COPD), a chronic inflammatory lung disease, is a leading cause of morbidity and mortality worldwide. Prolonged cigarette smoking (CS) that causes irreversible airway remo...

    Authors: Wensi Zhu, Linxiao Han, Yuanyuan Wu, Lin Tong, Ludan He, Qin Wang, Yu Yan, Ting Pan, Jie Shen, Yuanlin Song, Yao Shen, Qiaoliang Zhu and Jian Zhou
    Citation: Respiratory Research 2023 24:297
  39. The tachykinins, substance P and neurokinin A, present in sensory nerves and inflammatory cells such as macrophages and dendritic cells, are considered as pro-inflammatory agents. Inflammation of the airways a...

    Authors: Katelijne O De Swert, Ken R Bracke, Tine Demoor, Guy G Brusselle and Guy F Joos
    Citation: Respiratory Research 2009 10:37
  40. The opinions held by the general population on obstructive lung disease and inhaler devices could influence asthma and chronic obstructive pulmonary disorder (COPD) management and treatment adherence.

    Authors: Fulvio Braido, Ilaria Baiardini, Massimo Sumberesi, Francesco Blasi and Giorgio Walter Canonica
    Citation: Respiratory Research 2013 14:94
  41. There is strong evidence that oxidative stress is associated with the pathogenesis of chronic obstructive pulmonary disease (COPD). The transient receptor potential melastatin-2 (TRPM2) is an oxidative stress ...

    Authors: Liz Hardaker, Parmjit Bahra, Benjamin Cochin de Billy, Mark Freeman, Natalia Kupfer, Daniel Wyss and Alexandre Trifilieff
    Citation: Respiratory Research 2012 13:30
  42. Environmental pollution is a known risk factor for multiple diseases and furthermore increases rate of hospitalisations. We investigated the correlation between emergency room admissions (ERAs) of the general ...

    Authors: Pierachille Santus, Antonio Russo, Enzo Madonini, Luigi Allegra, Francesco Blasi, Stefano Centanni, Antonio Miadonna, Gianfranco Schiraldi and Sandro Amaducci
    Citation: Respiratory Research 2012 13:95
  43. Chronic Obstructive Pulmonary Disease (COPD) is a common, multifactorial lung disease which results in significant impairment of patients’ health and a large impact on society and health care burden. It is bel...

    Authors: Helena Crisford, Elizabeth Sapey and Robert A. Stockley
    Citation: Respiratory Research 2018 19:180
  44. Active smoking is the main risk factor for COPD. Here, epigenetic mechanisms may play a role, since cigarette smoking is associated with differential DNA methylation in whole blood. So far, it is unclear wheth...

    Authors: Maaike de Vries, Ivana Nedeljkovic, Diana A. van der Plaat, Alexandra Zhernakova, Lies Lahousse, Guy G. Brusselle, Najaf Amin, Cornelia M. van Duijn, Judith M. Vonk and H. Marike Boezen
    Citation: Respiratory Research 2019 20:268

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.9 - 5-year Impact Factor
    1.444 - SNIP (Source Normalized Impact per Paper)
    1.753 - SJR (SCImago Journal Rank)

    2023 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    105 days submission to accept (Median)

    2023 Usage 
    2,949,876 downloads
    2,397 Altmetric mentions